World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 May 2023
Main ID:  PACTR201310000589295
Date of registration: 12/07/2013
Prospective Registration: No
Primary sponsor:
Public title: Psychosocial Treatment for Methamphetamine Use Disorders in South Africa: A Pilot Study of a Cognitive Behavioural Therapy Program
Scientific title: Psychosocial Treatment for Methamphetamine Use Disorders in South Africa: A Pilot Study of a Cognitive Behavioural Therapy Program
Date of first enrolment: 01/07/2013
Target sample size: 60
Recruitment status: Recruiting
URL:  https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=589
Study type:  Interventional
Study design:  Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomisation using a radomisation table created by a computer software program,Sealed opaque envelopes  
Phase:  Not Applicable
Countries of recruitment
South Africa
Contacts
Name: Katherine     Sorsdahl
Address: 
Telephone: 021 650 6567
Email: katherine.sorsdahl@uct.ac.za
Affiliation: 
Name: Katherine    Sorsdahl
Address: 
Telephone: 021 650 6567
Email: katherine.sorsdahl@uct.ac.za
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: -Between 18 and 65 years of age
-Must meet DSM-IV criteria for methamphetamine abuse or dependence according to the Mini-International Psychiatric Interview (MINI) substance use module
-Methamphetamine must be their drug of choice. - Patients can have comorbid substance use disorders will not be excluded.

Exclusion criteria: -Exclusion criteria will include bipolar disorder, suicidality, schizophrenia and antisocial personality disorder (as assessed on the MINI).

Age minimum: 18 Year(s)
Age maximum: 60 Year(s)
Gender: Both
Health Condition(s) or Problem(s) studied

Methamphetamine Use Disorders
Methamphetamine Use Disorders
Intervention(s)
Control Group
Primary Outcome(s)
Frequency of methamphetamine use (days per week) validated with drug tests
Secondary Outcome(s)
Anxiety
Quality of LIfe
Depression
Methamphetamine Cravings
Severity of Meth Use Disorder
Disability
Secondary ID(s)
Source(s) of Monetary Support
Department of Psychiatry & Mental Health, University of Cape Town
Secondary Sponsor(s)
Department of Psychiatry & Mental Health, University of Cape Town
Ethics review
Status: Approved
Approval date: 06/02/2013
Contact:
URC- Health Sciences University of Cape Town
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history